Repaglinide - repaglinide
Navigation: NDC > Supplier starting with: M > MYLAN PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 0378-3121 |
| Proprietary Name: | Repaglinide |
| Suffix: | |
| Non-Proprietary Name: | repaglinide |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 27-08-2013 |
| Category Name: | ANDA |
| Application Number: | ANDA090252 |
| Labeler: | MYLAN PHARMACEUTICALS INC. |
| Substance Name: | REPAGLINIDE |
| Active Numerator Strength: | .5 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
| DEA Schedule: |